Patients With Hypertrophic Cardiomyopathy and Normal Genetic Investigations Have Few Affected Relatives
Søren K. Nielsen(University of Southern Denmark), Jens Mogensen(Odense University Hospital), Jens Flensted Lassen(University of Southern Denmark), Thomas Fischer(Lillebaelt Hospital), Ib Christian Klausen(Regionshospitalet Viborg), John Brodersen(University of Copenhagen), Trine Madsen(Aalborg University Hospital), Dorthe Svenstrup Møller(Regionshospitalet Viborg), Frederikke Hansen(Odense University Hospital), Torsten B. Rasmussen(Aarhus University Hospital), Morten K. Jensen(Aarhus University Hospital)
Cited by 13
Related Papers
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2013|3.4k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
Diagnostic Performance of Noninvasive Fractional Flow Reserve Derived From Coronary Computed Tomography Angiography in Suspected Coronary Artery Disease
|Journal of the American College of Cardiology|2014|1.5k
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
Risk Factors for Malignant Ventricular Arrhythmias in Lamin A/C Mutation Carriers
|Journal of the American College of Cardiology|2012|519